References
- Al-Jameil N, Aziz Khan F, Fareed Khan M, et al. A brief overview of preeclampsia. J Clin Med Res. 2014;6(1):1–7.
- Rayman MP, Barlis J, Evans RW, et al. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am J Obstet Gynecol. 2002;187(2):412–418.
- Muñoz M, Villar I, García-Erce JA. An update on iron physiology. World J Gastroenterol. 2009;15(37):4617–4626.
- Braekke K, Ueland PM, Harsem NK, et al. Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia. Pediatr Res. 2009;66(4):411–415.
- WHO. Daily iron and folic acid supplementation during pregnancy [Internet]. WHO. [cited 2017 Sep 16]. Available from: http://www.who.int/elena/titles/guidance_summaries/daily_iron_pregnancy/en/.
- Bresgen N, Eckl PM. Oxidative stress and the homeodynamics of iron metabolism. Biomolecules. 2015;5(2):808–847.
- Siddiqui IA, Jaleel A, Kadri H, et al. Iron status parameters in preeclamptic women. Arch Gynecol Obstet. 2011;284(3):587–591.
- Toldi G, Stenczer B, Molvarec A, et al. Hepcidin concentrations and iron homeostasis in preeclampsia. Clin Chem Lab Med. 2010;48(10):1423–1426.
- Schulze KJ, Christian P, Ruczinski I, et al. Hepcidin and iron status among pregnant women in Bangladesh. Asia Pac J Clin Nutr. 2008;17(3):451–456.
- Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823(9):1434–1443.
- Guideline: Daily iron and folic acid supplementation in pregnant women. National Health Portal Of India [Internet]. [cited 2017 Oct 4]. Available from: https://www.nhp.gov.in/guideline-daily-iron-and-folic-acid-supplementation-in-pregnant-women_pg.
- WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia | National Health Portal of India [Internet]. [cited 2017 Oct 4]. Available from: https://www.nhp.gov.in/who-recommendations-for-prevention-and-treatment-of-pre-eclampsia-and-eclampsia_pg.
- New ACOG Guidelines Just Released [Internet]. [cited 2017 Oct 4]. Available from: https://www.preeclampsia.org/the-news/3-newsflash/295-new-acog-guidelines-just-released.
- Yagi K. [39] Assay for blood plasma or serum. In: Methods in Enzymology [Internet]. Academic Press; 1984 [cited 2018 Jun 23]. p. 328–31. (Oxygen Radicals in Biological Systems; vol. 105). Available from: http://www.sciencedirect.com/science/article/pii/S0076687984050424.
- Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay. Anal Biochem. 1996;239(1):70–76.
- Yamanishi H, Iyama S, Yamaguchi Y, et al. Total iron-binding capacity calculated from serum transferrin concentration or serum iron concentration and unsaturated iron-binding capacity. Clin Chem. 2003;49(1):175–178.
- Eleftheriadis T, Liakopoulos V, Antoniadi G, et al. Which is the best way for estimating transferrin saturation? Ren Fail. 2010;32(8):1022–1023.
- Koenig MD, Tussing-Humphreys L, Day J, et al. Hepcidin and iron homeostasis during pregnancy. Nutrients. 2014;6(8):3062–3083.
- Zehra A, Saleh Abdullah SM, Saboor M, et al. Effect of intravenous iron supplementation on hepcidin levels in iron deficient pregnant females in second and third trimester. Indian J Hematol Blood Transfus. 2017;33(3):396–401.
- Yesmin F, Islam MS, Ferdoushi S, et al. Evaluation of serum ferritin concentration in mild and severe pre-eclamptic women. Mymensingh Med J. 2016;25(1):119–125.
- Song Q-Y, Luo W-P, Zhang C-X. High serum iron level is associated with an increased risk of hypertensive disorders during pregnancy: a meta-analysis of observational studies. Nutr Res. 2015;35(12):1060–1069.
- Scindia Y, Dey P, Thirunagari A, et al. Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis. J Am Soc Nephrol. 2015;26(11):2800–2814.